Advertisement

Topics

BioSyent’s Share Price Drops on Q3 Earnings

18:30 EST 21 Nov 2018 | Investing News Network

Rene Geohrum, CEO of BioSyent, said the decrease in international revenue was the result of “restrictions in a particular export market.”

The post BioSyent’s Share Price Drops on Q3 Earnings appeared first on Investing News Network.

Original Article: BioSyent’s Share Price Drops on Q3 Earnings

NEXT ARTICLE

More From BioPortfolio on "BioSyent’s Share Price Drops on Q3 Earnings"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...